As cases of measles continue to spread nationwide here are some helpful resources and answers to questions you may be facing in your practice.
The Ministry of Health is reminding all healthcare professionals and those working in health care facilities, born on 1 January 1969 or later, to ensure they are protected against measles.
Updates from Hauora Tairāwhiti GP liaison Anna Meuli.
PHARMAC is now funding the
new hepatitis C treatment, Maviret, a potential
cure for people with chronic hepatitis C infection regardless of the type or
A public campaign to eradicate hepatitis C in Tairāwhiti. Read more.
An Advance Care Plan (ACP) is an articulation of a patient's wishes, preferences, values and goals relevant to all current and future healthcare, including end of life care.
Read the latest flu and other vaccination updates here.
Pinnacle MHN offers screening support services for BreastScreen Aotearoa
and the National Cervical Screening Programme in Waikato.
Short videos from Attitude TVs piece on immunisation.
Read more about the concern raised about the accuracy of point of care testing for the
International Normalised Ratio (INR).
A closed access Facebook group for Pinnacle GPs to share ideas
A message from Dr Maree McCracken, GP liaison - mental health.
changes from September will mean a change in reporting of Tropinin I testing - read more.
Read about the initiation of the Mental Health Act process here.
The proposed "go live" date for bowel cancer screening in the Lakes DHB has been deferred to February 2019. Read more, including key messages for GPs and practices.
MHN contract directly with Waikato community podiatrists to provide care for
patients with diabetes who have a high-risk foot. Read more.
Read the latest cervical screening updates here.
Recent changes and what they mean for the NZ health sector.
For GPs across the network - find information and training resources about the use of dermatoscopes here.
Health professionals are encouraged to discuss the benefits and
risks of taking antiepileptic medicine during pregnancy with female
patients who are sexually active.